VIRGINIA BRADSHAW: Open Payments
NPI 1598795007 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,312 in 205 payments from 24 companies in 2025. Trend: 2023 $3,787 · 2024 $4,083 · 2025 $4,312
Food & beverage: $4,233Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $709 |
| UCB, Inc. | 27 | $663 |
| Janssen Biotech, Inc. | 31 | $582 |
| Novartis Pharmaceuticals Corporation | 26 | $487 |
| Regeneron Healthcare Solutions, Inc. | 8 | $285 |
| Galderma Laboratories, L.P. | 14 | $241 |
| Lilly USA, LLC | 7 | $230 |
| Incyte Corporation | 9 | $178 |
| E.R. Squibb & Sons, L.L.C. | 13 | $169 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $156 |
Products named: Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, RINVOQ, NEMLUVIO, OPZELURA.
Industry payments across TN — which companies pay providers there.
